BR9607673A - Processo para estimular a meiose de uma célula germinativa e uso de um composto que causa o acúmulo de uma substância endógena ativadora de meiose - Google Patents

Processo para estimular a meiose de uma célula germinativa e uso de um composto que causa o acúmulo de uma substância endógena ativadora de meiose

Info

Publication number
BR9607673A
BR9607673A BR9607673A BR9607673A BR9607673A BR 9607673 A BR9607673 A BR 9607673A BR 9607673 A BR9607673 A BR 9607673A BR 9607673 A BR9607673 A BR 9607673A BR 9607673 A BR9607673 A BR 9607673A
Authority
BR
Brazil
Prior art keywords
meiosis
accumulation
compound
causes
germ cell
Prior art date
Application number
BR9607673A
Other languages
English (en)
Inventor
Erling Guddal
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR9607673A publication Critical patent/BR9607673A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0608Germ cells
    • C12N5/0609Oocytes, oogonia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0608Germ cells
    • C12N5/061Sperm cells, spermatogonia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR9607673A 1995-03-06 1996-03-06 Processo para estimular a meiose de uma célula germinativa e uso de um composto que causa o acúmulo de uma substância endógena ativadora de meiose BR9607673A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK23295 1995-03-06
DK30995 1995-03-24
PCT/DK1996/000093 WO1996027658A1 (en) 1995-03-06 1996-03-06 Stimulation of meiosis

Publications (1)

Publication Number Publication Date
BR9607673A true BR9607673A (pt) 1998-06-16

Family

ID=26063579

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9607673A BR9607673A (pt) 1995-03-06 1996-03-06 Processo para estimular a meiose de uma célula germinativa e uso de um composto que causa o acúmulo de uma substância endógena ativadora de meiose

Country Status (13)

Country Link
US (1) US5830757A (pt)
EP (1) EP0813595A1 (pt)
JP (1) JPH11501806A (pt)
KR (1) KR19980702624A (pt)
AU (1) AU717180B2 (pt)
BR (1) BR9607673A (pt)
CA (1) CA2214126A1 (pt)
CZ (1) CZ279797A3 (pt)
HU (1) HUP9800731A3 (pt)
NO (1) NO974089L (pt)
PL (1) PL322106A1 (pt)
RU (1) RU2188006C2 (pt)
WO (1) WO1996027658A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0946584B1 (en) 1996-12-20 2003-04-23 Novo Nordisk A/S Meiosis regulating compounds
ES2189173T3 (es) * 1997-05-16 2003-07-01 Akzo Nobel Nv Derivados de 20-aril-5alfa-pregnano.
ATE215555T1 (de) 1997-06-04 2002-04-15 Akzo Nobel Nv 17-beta.-allyloxy(thio)alkyl-androstan derivative zur modulation von meiose
US6251887B1 (en) 1997-12-18 2001-06-26 Akzo Nobel N.V. 17β-aryl(arylmethyl)oxy(thio)alkyl-androstane derivatives
EP0957108A1 (en) * 1998-05-14 1999-11-17 Schering Aktiengesellschaft Unsaturated cholestane derivatives, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments
IL139241A0 (en) 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
EP1098652A2 (en) * 1998-05-26 2001-05-16 Schering Aktiengesellschaft Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
WO1999067273A1 (en) * 1998-06-19 1999-12-29 Novo Nordisk A/S Meiosis regulating compounds
ES2185360T3 (es) 1998-12-11 2003-04-16 Akzo Nobel Nv Derivados de 22s-hidroxicolesta-8,14-dieno con actividad reguladora de la meiosis.
AU3279700A (en) * 1999-02-10 2000-08-29 Schering Aktiengesellschaft Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
ATE317266T1 (de) * 1999-02-24 2006-02-15 Novo Nordisk As In vitro methode zur synchronisation von oozytenreifung
ATE361091T1 (de) * 1999-02-24 2007-05-15 Novo Nordisk As Behandlung von unfruchtbarkeit
CZ20012671A3 (cs) * 1999-02-26 2002-01-16 Novo Nordisk A/S Způsob in vitro oplodnění s pouľitím kultivačního média obsahujícího sterol aktivující meiosu
ATE229538T1 (de) * 1999-03-09 2002-12-15 Akzo Nobel Nv 22r-hydroxycholesta-8,14-diene derivate zur hemmung der meiose
EA200101157A1 (ru) * 1999-05-10 2002-06-27 Шеринг Акциенгезельшафт 14β-H-СТЕРОЛЫ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ЭТИХ ПРОИЗВОДНЫХ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ, РЕГУЛИРУЮЩИХ МЕЙОЗ
IL148234A0 (en) 1999-09-16 2002-09-12 Novo Nordisk As Composition for ivf
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
WO2001088098A2 (en) * 2000-05-18 2001-11-22 Schering Aktiengesellschaft Fertilization of aged oocytes
EP1216701A1 (en) * 2000-12-22 2002-06-26 Schering Aktiengesellschaft Process to increase the concentration of meiosis-activating sterols (MAS) in the cholesterol synthesis and the use of potent inhibitors in the process
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
US20050020666A1 (en) * 2003-07-25 2005-01-27 Dabur Research Foundation Cardioprotective agents
US20090105333A1 (en) * 2006-05-22 2009-04-23 Gunther Birznieks Melatonin agonist treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols

Also Published As

Publication number Publication date
HUP9800731A2 (hu) 1998-07-28
AU717180B2 (en) 2000-03-16
RU2188006C2 (ru) 2002-08-27
KR19980702624A (ko) 1998-08-05
US5830757A (en) 1998-11-03
CA2214126A1 (en) 1996-09-12
CZ279797A3 (cs) 1998-01-14
EP0813595A1 (en) 1997-12-29
AU4784596A (en) 1996-09-23
HUP9800731A3 (en) 2000-03-28
PL322106A1 (en) 1998-01-05
NO974089D0 (no) 1997-09-05
MX9706565A (es) 1997-11-29
JPH11501806A (ja) 1999-02-16
WO1996027658A1 (en) 1996-09-12
NO974089L (no) 1997-09-05

Similar Documents

Publication Publication Date Title
BR9607673A (pt) Processo para estimular a meiose de uma célula germinativa e uso de um composto que causa o acúmulo de uma substância endógena ativadora de meiose
BR9601324A (pt) Mistura de estabilizador composição processo para establizar um material orgânico e composto
BR9504359A (pt) Composto composição processo para estabilizar material orgânico e uso
BR9306070A (pt) Conexão tubular processo de estabilizar uma conexão tubular rosca para uso em conexões tubulares e peça de conexão tubular
BR9602705A (pt) Composto composição farmacéutica processo para a preparação de um composto e uso
BR9600146A (pt) Mistura composição processo para estabilizar material orgânico e uso
BR9600340A (pt) Composto composição e processo para estabilizar um material orgânico
NO942933D0 (no) Lastanvisende festeelement
BR9001311A (pt) Composicao estabilizada contra os efeitos nocivos de luz actinica e processo para estabilizar um material organico
BR9609695A (pt) Composição herbicida sinérgica e processo para seu uso
BR9505700A (pt) Processo para e preparação contínua de isocianatos orgânicos
BR9303438A (pt) Processo para preparar compostos de borracha e composto de borracha assim preparado
BR9800718A (pt) Composto esteróide composição farmacéutica uso de um composto esteróide e processo para a preparação de um estróide
BR9604823A (pt) Processo para controlar funggs nocivos e pragas fúngicas mistura sinérgica adequada para controlar pragas fúngicas e uso de compostos
BR9610042A (pt) Mistura fungicida processo para controlar fungos nocivos e uso de um composto
BR9610003A (pt) Mistura fungicida processo para controlar fungos nocivos e uso de um composto
FI942528A (fi) Kenkä ja menetelmä kengän kiinnittämiseksi
BR9801046A (pt) Processo para a preparação de um composto e uso de ácido tricloroisocianúrico
BR9405825A (pt) Uso de um esteróide esteróide processo para a preparação do mesmo e composição farmacéutica
BR9610420A (pt) Mistura fungicida processo para controlar fungos nocivos e uso de um composto
BR8904006A (pt) Processo para o hidrocraqueamento de carga de alimentacao hidrocarbonacea
BR9603767A (pt) Processo para revestir couro e composição para executar o mesmo
BR9406706A (pt) Elemento de construçao e processo de construçao que faz uso de elementos de construçao
BR9610002A (pt) Mistura fungicida processo para controlar fungos danosos e uso de um composto
DE9315399U1 (de) Flügelmutter

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/7048 (2006.01), A61K 31/00 (2006.0